What can the QBSafe trial teach us about person-centered diabetes care? Explore its findings on A1C, medication adherence, and patient priorities.
Read More »The Hidden Cost of Diabetes Care: Why Treatment Burden Is Becoming a Clinical Outcome
Managing diabetes has never offered more therapeutic options. Continuous glucose monitors (CGMs), automated insulin delivery systems, GLP-1 receptor agonists, SGLT2 inhibitors, and individualized treatment plans have transformed patient care. Yet despite these advances, many people with diabetes continue to struggle, not because treatments are ineffective, but because the overall workload …
Read More »Talking About Off‑Label GLP‑1 Use: How to Answer Patients Without Overpromising
A patient walks into your exam room, hopeful after reading that a diabetes drug might help with memory loss, addiction, or even anxiety. You know they’re talking about GLP‑1s—but how do you respond when the science is still unfolding? As GLP‑1 receptor agonists capture public attention for much more than …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.